02/04/2022 Amylyx Pharmaceuticals presents safety results from its PEGASUS clinical trial for AD Science watch
01/04/2022 Researchers discover novel protein aggregates that accumulate in the brain during aging Science watch
28/03/2022 Prothena Corporation announces FDA clearance of investigational new drug application for PRX012 for the treatment of AD Science watch
23/03/2022 Athira Pharma presents an overview from its ACT-AD Phase II Trial in mild to moderate AD Science watch
20/03/2022 TouchNEUROLOGY discusses new therapeutics for neurodegeneration, as well as sargramostim for mild-to-moderate Alzheimer’s disease during AD/PD 2022 conference Science watch
16/03/2022 Alector presents data from its INFRONT-2 Phase II trial for frontotemporal dementia Science watch
01/03/2022 Research study reveals a new genetic risk factor for cognitive decline in people with dominantly inherited Alzheimer's disease Science watch
28/02/2022 Therapeutics receives approval of Chinese clinical trial application for varoglutamstat in AD Science watch
